Phagos

Suresnes, France · Founded 2021 · Privately Held (backing)

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. Phagos is based in Suresnes, France and was founded in 2021. It was valued at $59.9 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $31.9 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2022.

PMV mark · valuation
$59.9M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$31.9M
Last round
Seed Round
Jul 2022

Who backs Phagos?

26 investors
InvestorType
BpifranceOther
Entrepreneurs FirstVenture capital
AWS StartupsOther
AgoranovOther
StartLifeOther
AgFunderVenture capital
Hoxton VenturesOther
Demeter PartnersPE / buyout
Citizen CapitalOther
Acurio Ventures Partners—
+ 16 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Phagos investors

26 investors are on record for Phagos, including Bpifrance, Entrepreneurs First, AWS Startups and Agoranov. The seed round in Jul 2022 drew 7 investors.

Free account
More of Phagos with a free account
  • ·The complete investor list: 26 names
  • ·Watch Phagos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 26 firms already write checks for companies like Phagos. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View